Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
3
×
amgen
biotech
boston blog main
boston top stories
national
national top stories
new york blog main
new york top stories
pfizer
san francisco blog main
san francisco top stories
abbvie
allergan aesthetics
alzheimer's disease
artificial intelligence
astrazeneca
athira pharma
attralus
biontech
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
chiesi farmaceutici
cholestatic liver diseases
cholesterol
click therapeutics
clinical trials
covid-19
cullinan oncology
cystic fibrosis
daniel o'day
data
deals
detroit blog main
detroit top stories
diabetic macular edema
What
ceo
3
×
drug
3
×
announced
medicine
week
aces
acquisitions
alex
big
biggest
bio
build
buy
cholesterol
collaboration
company’s
daniel
debut
discovery
dyne’s
entered
flexible
gilead
inclisiran
insilico
key
lowering
meant
medco
medicines
microbiome
moves
nasdaq
open
openly
o’day
passed
pfizer
pipeline
pricing
Language
unset
3
×
Current search:
drug
×
unset
×
" national blog main "
×
ceo
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing